AzTrials
AzTrials

Hearing LossPhase 4NCT00331539

Relationship Between Auto NRT and Behavioural T & C Levels With the Nucleus Freedom Cochlear Implant

A Phase 4 study testing Cochlear Implant in people with Hearing Loss, run by Bnai Zion Medical Center at 1 site in Israel.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Cochlear implants require programming on an individual basis to provide appropriate levels of electrical stimulation. This program, or "map", is placed in the speech processor of the cochlear implant. Success of implantation largely depends on the adequacy of this map. Read more about this study

Who is it for?
Ages 12 years and olderHealthy volunteers can take part
Conditions the study is for
Hearing Loss
What is being tested?
Cochlear Implant
Type of treatment
Medical device
How many people
20 participants
Where
1 siteIsrael
Study dates
May 2006to Jun 2008
Phase
Phase 4
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 12 years and older
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Inclusion Criteria:Patients eligible for the study should be capable of providing reliable subjective counted thresholds (e.g. children older than 12 years of age at CI or adults) and has good NRT recordings, implanted with the Nucleus Freedom system

-

Exclusion Criteria:Implantees With any other serious illness, Who can not give a reliable subjective counted thresholds

-

Trial locations and contacts

1 site in 1 country.

Israel1 site, 1 recruiting
  • Bnai Zion MC

    Haifa, 31048

    Michal Luntz, MD, 972-4-8359544, michal.luntz@b-zion.org.il

    Michal Luntz, MD

    Recruiting

Other trials in Israel

About this study

Cochlear implants require programming on an individual basis to provide appropriate levels of electrical stimulation. This program, or "map", is placed in the speech processor of the cochlear implant. Success of implantation largely depends on the adequacy of this map. Cochlear implant fitting remains a difficult challenge in congenitally or pre-linguistically deafened children. It requires competence of experienced audiologists with expertise in behavioral techniques for hearing function assessment.Our goal is to establish the offset correlation between objective measurements (NRT and ESRT) and the behavioral measurements of T \& Cs in different stimulation rates in the Freedom SP System.

Read the detailed description

An open trail. The implantees will go through their routine programming sessions after implantation, the specified data will be collected and analyzed in order to establish the offset correlation which we seek for.

Conditions
Hearing Loss
Being tested
Cochlear Implant
Keywords
Cochlear implant, threshold (T) measurement, comfort (C) level, profound hearing loss, auditory stimuli, profound hearing loss patients eligible for the study should be capable of providing reliable, subjective counted thresholds and has good NRT recordings, implanted with, the Nucleus Freedom system
Medical subject headings
Hearing Loss

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Cochlear ImplantDevice

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. To find possible correlation between behavioral counted T & C levels at different stimulation rates and NRT thresholds using the Auto NRT and ESRT over time, from switch on up to 12 months period.

  2. To find possible changes over time in NRT thresholds (12 months period).

  3. To find possible changes over time in ESRT thresholds (9 months period) starting 3 months post-op.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted31 May 2006 (estimated)
  2. Study startMay 2006
  3. Study completionJun 2008

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 4
Primary purpose
Treatment
Allocation
Non-randomised
Intervention model
Single group
Masking
None (open label)
Enrolment
20 participants
IDs, dates and publications
ClinicalTrials.gov ID
NCT00331539
Sponsor's protocol ID
BnaiZionMC-06-ML-002-CTIL
Status last verified
Jul 2005
First submitted
30 May 2006
Last updated
9 Oct 2006
Results posted
No

Questions about this trial

What is this clinical trial studying?

A Phase 4 study testing Cochlear Implant in people with Hearing Loss, run by Bnai Zion Medical Center at 1 site in Israel.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 9 Oct 2006. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Israel. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 4 studies take place after a treatment is approved, to learn more about its long-term benefits and risks in everyday use.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Michal Luntz, MD (972-4-8359544, michal.luntz@b-zion.org.il), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

To find possible correlation between behavioral counted T & C levels at different stimulation rates and NRT thresholds using the Auto NRT and ESRT over time, from switch on up to 12 months period.. The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Oct 2006.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in